Powered by

Novartis and Adamis' EpiPen challenger launches at double-digit discount

Jan 17, 2019 - FiercePharma
Product Launch

Buckle up, Mylan, another epinephrine injection is in town—and its sticker price is lower than your own generic EpiPen's cut-rate cost.

Adamis Pharmaceuticals and its commercial partner, Novartis' Sandoz unit, announced Wednesday they had officially launched the 0.3 mg dose of Symjepi, a prefilled epinephrine syringe meant for the emergency treatment of allergic reactions.

Sandoz has set the wholesale acquisition cost for a Symjepitwo-pack at $250, lower than the $300 price of Myla...